Gamida Cell Ltd
Biotechnology
Healthcare
GMDA
63.83 M shares
NASDAQ US
traded
01 Aug 2023
listed
yes
open
1.43
52 week high
3.39
high
1.43
52 week low
1.32
low
1.39
growth
-53.49 %
previous Close
1.43
P/E ratio
market cap
174 M
div yield
0
usd
Mar 2023
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
0.00 %
eps surprise
100.00 %
net profit margin
0.00 %
0.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top